Clinical trial Recruiting at 1 site Phase 1 Interventional Ages 18 and up

Understanding brain activity changes during ketamine treatment for psychiatric disorders

Official title: HNC: Human Neural Circuits Electrophysiology During Cognition

Run by Stanford University · NCT05962424 · Data updated 2026-11-12

This study is testing how ketamine changes brain activity in patients with psychiatric disorders to better understand its benefits and side effects during treatment.

Quick facts

PhasePhase 1
Study typeInterventional
Ages18 Years and up
SexAll
Enrollment120 (estimated)
SponsorStanford University
Academic / other
Locations1 site (Palo Alto, California)
StatusRecruiting
StartedOctober 5, 2023
Main results expectedSeptember 1, 2030
Study endsSeptember 1, 2030
Registry record updatedNovember 5, 2026
Trial IDNCT05962424 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults over 18 years old who are currently in clinical neuro inpatient units at Stanford Medical Center.

Probably not a fit

Patients with a lifetime history of psychotic disorders, pregnant or nursing females, or those who have had an adverse response to ketamine may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This research aims to investigate how ketamine affects brain activity and leads to dissociative symptoms in patients undergoing antidepressant therapy. By recording neural circuits during cognitive tasks, the study seeks to uncover the mechanisms behind the therapeutic effects of ketamine and its side effects. The focus is on patients in clinical neuro inpatient units at Stanford Medical Center, where the effects of ketamine will be closely monitored and analyzed.

Why it matters

Potential benefit: If successful, this study could enhance our understanding of ketamine's effects, leading to improved treatment strategies for psychiatric disorders.

How similar studies have gone: Other studies have explored ketamine's effects on brain activity, but this specific approach to understanding dissociation during treatment is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patient in clinical neuro inpatient units at Stanford Medical Center
* Age \>18 years old
* Female participants are expected to use an effective method of birth control throughout the study which includes: hormonal methods (birth control pills, patches, injections, vaginal ring or implants), barrier methods (condom or diaphragm) used with spermicide, intrauterine device (IUD), or abstinence (no sex)

Exclusion Criteria:

* Lifetime psychotic disorder
* Pregnant or nursing females
* Prior adverse ketamine response
* Use of ketamine in past 7 days

Where it's running

  • Stanford University
    Palo Alto, California, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.